BACKGROUND: Hypertrophic cardiomyopathy (HCM) is one of the most common genetic cardiovascular disorders. Mutations in the MYBPC3 gene are one of the most frequent genetic causes of HCM. OBJECTIVES: To screen MYBPC3 gene mutations in Chinese patients with HCM, and analyze the correlation between the genotype and the phenotype. METHODS: The 35 exons of the MYBPC3 gene were amplified by polymerase chain reaction in the 11 consecutive unrelated Chinese pedigrees. The sequences of the products were analyzed and the mutation sites were determined. The clinical data of genotype-positive families were collected, and the correlation between genotype and phenotype was analyzed. RESULTS: Two mutations of the MYBPC3 gene were confirmed among 11 pedigrees. A frameshift mutation (Pro459fs) was identified in exon 17 in family H8, and a splice mutation (IVS5+5G−>C) was identified in intron 5 in family H3. These two mutations were first identified in Chinese patients with familial HCM and were absent in 110 chromosomes of healthy controls. Seven known polymorphisms were found in the cohort. CONCLUSIONS: Compared with what was reported abroad, the MYBPC3 gene is a common pathogenic gene responsible for HCM in Chinese patients, and the phenotypes of these two mutations in their respective families may have their own clinical characteristics.
BACKGROUND:Hypertrophic cardiomyopathy (HCM) is one of the most common genetic cardiovascular disorders. Mutations in the MYBPC3 gene are one of the most frequent genetic causes of HCM. OBJECTIVES: To screen MYBPC3 gene mutations in Chinese patients with HCM, and analyze the correlation between the genotype and the phenotype. METHODS: The 35 exons of the MYBPC3 gene were amplified by polymerase chain reaction in the 11 consecutive unrelated Chinese pedigrees. The sequences of the products were analyzed and the mutation sites were determined. The clinical data of genotype-positive families were collected, and the correlation between genotype and phenotype was analyzed. RESULTS: Two mutations of the MYBPC3 gene were confirmed among 11 pedigrees. A frameshift mutation (Pro459fs) was identified in exon 17 in family H8, and a splice mutation (IVS5+5G−>C) was identified in intron 5 in family H3. These two mutations were first identified in Chinese patients with familial HCM and were absent in 110 chromosomes of healthy controls. Seven known polymorphisms were found in the cohort. CONCLUSIONS: Compared with what was reported abroad, the MYBPC3 gene is a common pathogenic gene responsible for HCM in Chinese patients, and the phenotypes of these two mutations in their respective families may have their own clinical characteristics.
Authors: Barry J Maron; William J McKenna; Gordon K Danielson; Lukas J Kappenberger; Horst J Kuhn; Christine E Seidman; Pravin M Shah; William H Spencer; Paolo Spirito; Folkert J Ten Cate; E Douglas Wigle Journal: J Am Coll Cardiol Date: 2003-11-05 Impact factor: 24.094
Authors: Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron Journal: N Engl J Med Date: 2003-01-23 Impact factor: 91.245
Authors: Pertti Jääskeläinen; Johanna Kuusisto; Raija Miettinen; Päivi Kärkkäinen; Satu Kärkkäinen; Sami Heikkinen; Paula Peltola; Jussi Pihlajamäki; Ilkka Vauhkonen; Markku Laakso Journal: J Mol Med (Berl) Date: 2002-04-11 Impact factor: 4.599
Authors: Mario Torrado; Emilia Maneiro; Arsonval Lamounier Junior; Miguel Fernández-Burriel; Sara Sánchez Giralt; Ana Martínez-Carapeto; Laura Cazón; Elisa Santiago; Juan Pablo Ochoa; William J McKenna; Luis Santomé; Lorenzo Monserrat Journal: Sci Rep Date: 2022-05-04 Impact factor: 4.996
Authors: Kaoru Ito; Parth N Patel; Joshua M Gorham; Barbara McDonough; Steven R DePalma; Emily E Adler; Lien Lam; Calum A MacRae; Syed M Mohiuddin; Diane Fatkin; Christine E Seidman; J G Seidman Journal: Proc Natl Acad Sci U S A Date: 2017-07-05 Impact factor: 11.205